Literature DB >> 19692487

Mice lacking mPGES-1 are resistant to lithium-induced polyuria.

Zhanjun Jia1, Haiping Wang, Tianxin Yang.   

Abstract

Cyclooxygenase-2 activity is required for the development of lithium-induced polyuria. However, the involvement of a specific, terminal prostaglandin (PG) isomerase has not been evaluated. The present study was undertaken to assess lithium-induced polyuria in mice deficient in microsomal prostaglandin E synthase-1 (mPGES-1). A 2-wk administration of LiCl (4 mmol.kg(-1).day(-1) ip) in mPGES-1 +/+ mice led to a marked polyuria with hyposmotic urine. This was associated with elevated renal mPGES-1 protein expression and increased urine PGE(2) excretion. In contrast, mPGES-1 -/- mice were largely resistant to lithium-induced polyuria and a urine concentrating defect, accompanied by nearly complete blockade of high urine PGE(2) and cAMP output. Immunoblotting, immunohistochemistry, and quantitative (q) RT-PCR consistently detected a significant decrease in aquaporin-2 (AQP2) protein expression in both the renal cortex and medulla of lithium-treated +/+ mice. This decrease was significantly attenuated in the -/- mice. qRT-PCR detected similar patterns of changes in AQP2 mRNA in the medulla but not in the cortex. Similarly, the total protein abundance of the Na-K-2Cl cotransporter (NKCC2) in the medulla but not in the cortex of the +/+ mice was significantly reduced by lithium treatment. In contrast, the dowregulation of renal medullary NKCC2 expression was significantly attenuated in the -/- mice. We conclude that mPGES-1-derived PGE(2) mediates lithium-induced polyuria likely via inhibition of AQP2 and NKCC2 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692487      PMCID: PMC2801334          DOI: 10.1152/ajprenal.00117.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  60 in total

1.  Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium.

Authors:  R L Hébert; H R Jacobson; M D Breyer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 2.  Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.

Authors:  R Boton; M Gaviria; D C Batlle
Journal:  Am J Kidney Dis       Date:  1987-11       Impact factor: 8.860

3.  Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.

Authors:  S Christensen; E Kusano; A N Yusufi; N Murayama; T P Dousa
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  PGE2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation.

Authors:  R L Hébert; H R Jacobson; M D Breyer
Journal:  Am J Physiol       Date:  1990-08

5.  Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct.

Authors:  R L Hébert; H R Jacobson; D Fredin; M D Breyer
Journal:  Am J Physiol       Date:  1993-11

Review 6.  Lithium nephrotoxicity.

Authors:  R G Walker
Journal:  Kidney Int Suppl       Date:  1993-07       Impact factor: 10.545

7.  Lithium-induced nephrogenic diabetes insipidus treated with indomethacin.

Authors:  E J Martinez; J T Sinnott; G Rodriguez-Paz; R L Oehler
Journal:  South Med J       Date:  1993-08       Impact factor: 0.954

8.  Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2.

Authors:  Gheun-Ho Kim; Nak Won Choi; Ju-Young Jung; Ji-Hyun Song; Chang Hwa Lee; Chong Myung Kang; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

9.  Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney.

Authors:  S Nielsen; S R DiGiovanni; E I Christensen; M A Knepper; H W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria.

Authors:  M Sugawara; K Hashimoto; Z Ota
Journal:  Am J Physiol       Date:  1988-06
View more
  23 in total

Review 1.  Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  B K Kishore; N G Carlson; C M Ecelbarger; D E Kohan; C E Müller; R D Nelson; J Peti-Peterdi; Y Zhang
Journal:  Acta Physiol (Oxf)       Date:  2015-05-04       Impact factor: 6.311

2.  Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.

Authors:  Søren Brandt Poulsen; Tina Bøgelund Kristensen; Heddwen L Brooks; Donald E Kohan; Timo Rieg; Robert A Fenton
Journal:  JCI Insight       Date:  2017-04-06

3.  Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.

Authors:  Theun de Groot; Lena K Ebert; Birgitte Mønster Christensen; Karolina Andralojc; Lydie Cheval; Alain Doucet; Cungui Mao; Ruben Baumgarten; Benjamin E Low; Roger Sandhoff; Michael V Wiles; Peter M T Deen; Ron Korstanje
Journal:  J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 10.121

Review 4.  Outside the mainstream: novel collecting duct proteins regulating water balance.

Authors:  Shamma S Rahman; Erika I Boesen
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

5.  mPGES-1 deletion potentiates urine concentrating capability after water deprivation.

Authors:  Zhanjun Jia; Gang Liu; Maicy Downton; Zheng Dong; Aihua Zhang; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

6.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity.

Authors:  Ming-Zhi Zhang; Suwan Wang; Yinqiu Wang; Yahua Zhang; Chuan Ming Hao; Raymond C Harris
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

7.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 8.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

Review 9.  Lithium: a versatile tool for understanding renal physiology.

Authors:  Bellamkonda K Kishore; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-13

10.  Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.

Authors:  Soma Jobbagy; Dario A Vitturi; Sonia R Salvatore; Maria F Pires; Pascal Rowart; David R Emlet; Mark Ross; Scott Hahn; Claudette St Croix; Stacy G Wendell; Arohan R Subramanya; Adam C Straub; Roderick J Tan; Francisco J Schopfer
Journal:  JCI Insight       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.